{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:22Z","timestamp":1786979902722,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Education graduate research innovation project of HuNan Province","award":["XJT[2023]205"],"award-info":[{"award-number":["XJT[2023]205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04061-9","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T08:16:23Z","timestamp":1748247383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunotyping of thyroid cancer for clinical outcomes and implications"],"prefix":"10.1007","volume":"74","author":[{"given":"Jin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"issue":"6","key":"4061_CR1","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.eururo.2015.09.019","volume":"69","author":"A Aakula","year":"2016","unstructured":"Aakula A, Kohonen P, Leivonen SK, M\u00e4kel\u00e4 R, Hintsanen P, Mpindi JP, Martens-Uzunova E, Aittokallio T, Jenster G, Per\u00e4l\u00e4 M, Kallioniemi O, \u00d6stling P (2016) Systematic identification of MicroRNAs that impact on proliferation of prostate cancer cells and display changed expression in tumor tissue. Eur Urol 69(6):1120\u20131128. https:\/\/doi.org\/10.1016\/j.eururo.2015.09.019","journal-title":"Eur Urol"},{"issue":"3","key":"4061_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12020-015-0623-9","volume":"50","author":"F Abdolahi","year":"2015","unstructured":"Abdolahi F, Dabbaghmanesh MH, Haghshenas MR, Ghaderi A, Erfani N (2015) A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses. Endocrine 50(3):698\u2013707. https:\/\/doi.org\/10.1007\/s12020-015-0623-9","journal-title":"Endocrine"},{"key":"4061_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1471-2407-14-452","volume":"14","author":"M Adachi-Hayama","year":"2014","unstructured":"Adachi-Hayama M, Adachi A, Shinozaki N, Matsutani T, Hiwasa T, Takiguchi M, Saeki N, Iwadate Y (2014) Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas. BMC Cancer 14:452. https:\/\/doi.org\/10.1186\/1471-2407-14-452","journal-title":"BMC Cancer"},{"issue":"8","key":"4061_CR4","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.4049\/jimmunol.0801613","volume":"182","author":"G Alsaleh","year":"2009","unstructured":"Alsaleh G, Suffert G, Semaan N, Juncker T, Frenzel L, Gottenberg JE, Sibilia J, Pfeffer S, Wachsmann D (2009) Bruton\u2019s tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol 182(8):5088\u20135097. https:\/\/doi.org\/10.4049\/jimmunol.0801613","journal-title":"J Immunol"},{"issue":"1","key":"4061_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4132\/jptm.2017.07.26","volume":"52","author":"HJ An","year":"2018","unstructured":"An HJ, Ko GH, Lee JH, Lee JS, Kim DC, Yang JW, Kim MH, Kim JP, Jung EJ, Song DH (2018) Programmed death-ligand 1 expression and its correlation with lymph node metastasis in papillary thyroid carcinoma. J Pathol Transl Med 52(1):9\u201313. https:\/\/doi.org\/10.4132\/jptm.2017.07.26","journal-title":"J Pathol Transl Med"},{"issue":"5","key":"4061_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x","journal-title":"Nat Med"},{"issue":"3","key":"4061_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/cancers15030923","volume":"15","author":"BG Cavalheiro","year":"2023","unstructured":"Cavalheiro BG, Shah JP, Randolph GW, Medina JE, Tufano RP, Zafereo M, Hartl DM, Nixon IJ, Guntinas-Lichius O, Poorten VV, L\u00f3pez F, Khafif AH, Owen RP, Shaha A, Rodrigo JP, Rinaldo A, M\u00e4kitie AA, Silver CE, Sanabria A, Kowalski LP, Ferlito A (2023) Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: a Comprehensive Review. Cancers 15(3):923. https:\/\/doi.org\/10.3390\/cancers15030923","journal-title":"Cancers"},{"issue":"10","key":"4061_CR8","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1158\/0008-5472.Can-05-3012","volume":"66","author":"V Chabottaux","year":"2006","unstructured":"Chabottaux V, Sounni NE, Pennington CJ, English WR, van den Br\u00fble F, Blacher S, Gilles C, Munaut C, Maquoi E, Lopez-Otin C, Murphy G, Edwards DR, Foidart JM, No\u00ebl A (2006) Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res 66(10):5165\u20135172. https:\/\/doi.org\/10.1158\/0008-5472.Can-05-3012","journal-title":"Cancer Res"},{"issue":"6","key":"4061_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40618-017-0778-8","volume":"41","author":"P Chalan","year":"2018","unstructured":"Chalan P, Di Dalmazi G, Pani F, De Remigis A, Corsello A, Caturegli P (2018) Thyroid dysfunctions secondary to cancer immunotherapy. J Endocrinol Invest 41(6):625\u2013638. https:\/\/doi.org\/10.1007\/s40618-017-0778-8","journal-title":"J Endocrinol Invest"},{"issue":"10387","key":"4061_CR10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/s0140-6736(23)00020-x","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR (2023) Thyroid cancer. Lancet 401(10387):1531\u20131544. https:\/\/doi.org\/10.1016\/s0140-6736(23)00020-x","journal-title":"Lancet"},{"issue":"1","key":"4061_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s10238-024-01319-x","volume":"24","author":"D Chu","year":"2024","unstructured":"Chu D, Chen L, Li W, Zhang H (2024) An exosomes-related lncRNA prognostic model correlates with the immune microenvironment and therapy response in lung adenocarcinoma. Clin Exp Med 24(1):104. https:\/\/doi.org\/10.1007\/s10238-024-01319-x","journal-title":"Clin Exp Med"},{"issue":"3","key":"4061_CR12","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/erc-13-0431","volume":"21","author":"LL Cunha","year":"2014","unstructured":"Cunha LL, Marcello MA, Ward LS (2014) The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocr Relat Cancer 21(3):R85-r103. https:\/\/doi.org\/10.1530\/erc-13-0431","journal-title":"Endocr Relat Cancer"},{"key":"4061_CR13","doi-asserted-by":"publisher","first-page":"713001","DOI":"10.3389\/fimmu.2021.713001","volume":"12","author":"C Dong","year":"2021","unstructured":"Dong C, Dang D, Zhao X, Wang Y, Wang Z, Zhang C (2021) Integrative characterization of the role of IL27 in melanoma using bioinformatics analysis. Front Immunol 12:713001. https:\/\/doi.org\/10.3389\/fimmu.2021.713001","journal-title":"Front Immunol"},{"issue":"5","key":"4061_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.bbamcr.2011.02.004","volume":"1813","author":"H El Btaouri","year":"2011","unstructured":"El Btaouri H, Morjani H, Greffe Y, Charpentier E, Martiny L (2011) Role of JNK\/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells. Biochim Biophys Acta 1813(5):695\u2013703. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.02.004","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"4061_CR15","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A (2019) Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol 30(12):1856\u20131883. https:\/\/doi.org\/10.1093\/annonc\/mdz400","journal-title":"Ann Oncol"},{"issue":"6","key":"4061_CR16","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1158\/1078-0432.Ccr-18-1880","volume":"25","author":"P Foidart","year":"2019","unstructured":"Foidart P, Yip C, Radermacher J, Blacher S, Lienard M, Montero-Ruiz L, Maquoi E, Montaudon E, Ch\u00e2teau-Joubert S, Collignon J, Coibion M, Jossa V, Marangoni E, No\u00ebl A, Sounni NE, Jerusalem G (2019) Expression of MT4-MMP, EGFR, and RB in triple-negative breast cancer strongly sensitizes tumors to erlotinib and palbociclib combination therapy. Clin Cancer Res 25(6):1838\u20131850. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-1880","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4061_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/biom12040574","volume":"12","author":"M Garc\u00eda-S\u00e1enz","year":"2022","unstructured":"Garc\u00eda-S\u00e1enz M, Lobaton-Ginsberg M, Ferreira-Hermosillo A (2022) Metformin in differentiated thyroid cancer: molecular pathways and its clinical implications. Biomolecules 12(4):574. https:\/\/doi.org\/10.3390\/biom12040574","journal-title":"Biomolecules"},{"issue":"1","key":"4061_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/10717544.2017.1303856","volume":"24","author":"CL Gigliotti","year":"2017","unstructured":"Gigliotti CL, Ferrara B, Occhipinti S, Boggio E, Barrera G, Pizzimenti S, Giovarelli M, Fantozzi R, Chiocchetti A, Argenziano M, Clemente N, Trotta F, Marchi\u00f2 C, Annaratone L, Boldorini R, Dianzani U, Cavalli R, Dianzani C (2017) Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors. Drug Deliv 24(1):670\u2013680. https:\/\/doi.org\/10.1080\/10717544.2017.1303856","journal-title":"Drug Deliv"},{"issue":"6","key":"4061_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/s2213-8587(17)30325-x","volume":"6","author":"G Grani","year":"2018","unstructured":"Grani G, Lamartina L, Durante C, Filetti S, Cooper DS (2018) Follicular thyroid cancer and H\u00fcrthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol 6(6):500\u2013514. https:\/\/doi.org\/10.1016\/s2213-8587(17)30325-x","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"4061_CR20","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.1002\/cam4.5555","volume":"12","author":"P Guo","year":"2023","unstructured":"Guo P, Wang X, Xia L, Shawureding N, Hu Z (2023) Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model. Cancer Med 12(7):7868\u20137876. https:\/\/doi.org\/10.1002\/cam4.5555","journal-title":"Cancer Med"},{"issue":"1","key":"4061_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059","journal-title":"Cancer Discov"},{"key":"4061_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf 14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7","journal-title":"BMC Bioinf"},{"issue":"7","key":"4061_CR23","doi-asserted-by":"publisher","first-page":"e0158839","DOI":"10.1371\/journal.pone.0158839","volume":"11","author":"YH Huang","year":"2016","unstructured":"Huang YH, Yang HY, Huang SW, Ou G, Hsu YF, Hsu MJ (2016) Interleukin-6 induces vascular endothelial growth factor-C expression via Src-FAK-STAT3 signaling in lymphatic endothelial cells. PLoS ONE 11(7):e0158839. https:\/\/doi.org\/10.1371\/journal.pone.0158839","journal-title":"PLoS ONE"},{"key":"4061_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12935-020-1130-5","volume":"20","author":"X Huo","year":"2020","unstructured":"Huo X, Wang H, Huo B, Wang L, Yang K, Wang J, Wang L, Wang H (2020) FTX contributes to cell proliferation and migration in lung adenocarcinoma via targeting miR-335-5p\/NUCB2 axis. Cancer Cell Int 20:89. https:\/\/doi.org\/10.1186\/s12935-020-1130-5","journal-title":"Cancer Cell Int"},{"key":"4061_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biocel.2015.02.014","volume":"62","author":"JS Hwang","year":"2015","unstructured":"Hwang JS, Eun SY, Ham SA, Yoo T, Lee WJ, Paek KS, Do JT, Lim DS, Seo HG (2015) PPAR\u03b4 modulates oxLDL-induced apoptosis of vascular smooth muscle cells through a TGF-\u03b2\/FAK signaling axis. Int J Biochem Cell Biol 62:54\u201361. https:\/\/doi.org\/10.1016\/j.biocel.2015.02.014","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"4061_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/hmbci-2020-0051","volume":"42","author":"M Jamshidi","year":"2021","unstructured":"Jamshidi M, Farnoosh G, Mohammadi Pour S, Rafiee F, SaeediBoroujeni A, Mahmoudian-Sani MR (2021) Genetic variants and risk of thyroid cancer among Iranian patients. Horm Mol Biol Clin Investig 42(2):223\u2013234. https:\/\/doi.org\/10.1515\/hmbci-2020-0051","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"1","key":"4061_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/jpm13010085","volume":"13","author":"K Jiang","year":"2022","unstructured":"Jiang K, Bei Lin Y, Zhang KL, Fan W, Luo D (2022) A novel pyroptosis-related gene signature for prediction of disease-free survival in papillary thyroid carcinoma. J Personal Med 13(1):85. https:\/\/doi.org\/10.3390\/jpm13010085","journal-title":"J Personal Med"},{"issue":"8","key":"4061_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41416-019-0413-x","volume":"120","author":"M Kamil","year":"2019","unstructured":"Kamil M, Shinsato Y, Higa N, Hirano T, Idogawa M, Takajo T, Minami K, Shimokawa M, Yamamoto M, Kawahara K, Yonezawa H, Hirano H, Furukawa T, Yoshimoto K, Arita K (2019) High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme. Br J Cancer 120(8):819\u2013826. https:\/\/doi.org\/10.1038\/s41416-019-0413-x","journal-title":"Br J Cancer"},{"issue":"22","key":"4061_CR29","first-page":"6645","volume":"62","author":"A Kaneda","year":"2002","unstructured":"Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T (2002) Identification of silencing of nine genes in human gastric cancers. Cancer Res 62(22):6645\u20136650","journal-title":"Cancer Res"},{"issue":"12","key":"4061_CR30","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/carcin\/bgp158","volume":"30","author":"JS Kang","year":"2009","unstructured":"Kang JS, Bae SY, Kim HR, Kim YS, Kim DJ, Cho BJ, Yang HK, Hwang YI, Kim KJ, Park HS, Hwang DH, Cho DJ, Lee WJ (2009) Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. Carcinogenesis 30(12):1987\u20131996. https:\/\/doi.org\/10.1093\/carcin\/bgp158","journal-title":"Carcinogenesis"},{"issue":"11","key":"4061_CR31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41592-018-0185-x","volume":"15","author":"JM Kebschull","year":"2018","unstructured":"Kebschull JM, Zador AM (2018) Cellular barcoding: lineage tracing, screening and beyond. Nat Methods 15(11):871\u2013879. https:\/\/doi.org\/10.1038\/s41592-018-0185-x","journal-title":"Nat Methods"},{"key":"4061_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biocel.2018.07.012","volume":"103","author":"SB Kokate","year":"2018","unstructured":"Kokate SB, Dixit P, Poirah I, Roy AD, Chakraborty D, Rout N, Singh SP, Ashktorab H, Smoot DT, Bhattacharyya A (2018) Testin and filamin-C downregulation by acetylated Siah2 increases invasiveness of Helicobacter pylori-infected gastric cancer cells. Int J Biochem Cell Biol 103:14\u201324. https:\/\/doi.org\/10.1016\/j.biocel.2018.07.012","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"4061_CR33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1634\/theoncologist.2017-0096","volume":"22","author":"R Kollipara","year":"2017","unstructured":"Kollipara R, Schneider B, Radovich M, Babu S, Kiel PJ (2017) Exceptional response with immunotherapy in a patient with anaplastic thyroid cancer. Oncologist 22(10):1149\u20131151. https:\/\/doi.org\/10.1634\/theoncologist.2017-0096","journal-title":"Oncologist"},{"key":"4061_CR34","doi-asserted-by":"publisher","first-page":"1325343","DOI":"10.3389\/fimmu.2023.1325343","volume":"14","author":"A Kotwal","year":"2023","unstructured":"Kotwal A, Gustafson MP, Bornschlegl S, Dietz AB, Delivanis D, Ryder M (2023) Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer. Front Immunol 14:1325343. https:\/\/doi.org\/10.3389\/fimmu.2023.1325343","journal-title":"Front Immunol"},{"key":"4061_CR35","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-23-0240","author":"S Li","year":"2024","unstructured":"Li S, Chen Z, Liu M, Li L, Cai W, Lian ZX, Guan H, Bo X (2024) Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma. Endocr Relat Cancer. https:\/\/doi.org\/10.1530\/ERC-23-0240","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"4061_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2007.11.031","volume":"29","author":"ST Lim","year":"2008","unstructured":"Lim ST, Chen XL, Lim Y, Hanson DA, Vo TT, Howerton K, Larocque N, Fisher SJ, Schlaepfer DD, Ilic D (2008) Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 29(1):9\u201322. https:\/\/doi.org\/10.1016\/j.molcel.2007.11.031","journal-title":"Mol Cell"},{"issue":"7","key":"4061_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1083\/jcb.201109067","volume":"197","author":"ST Lim","year":"2012","unstructured":"Lim ST, Miller NL, Chen XL, Tancioni I, Walsh CT, Lawson C, Uryu S, Weis SM, Cheresh DA, Schlaepfer DD (2012) Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression. J Cell Biol 197(7):907\u2013919. https:\/\/doi.org\/10.1083\/jcb.201109067","journal-title":"J Cell Biol"},{"issue":"1","key":"4061_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12935-021-01824-z","volume":"21","author":"J Liu","year":"2021","unstructured":"Liu J, Liu Q, Zhang X, Cui M, Li T, Zhang Y, Liao Q (2021) Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. Cancer Cell Int 21(1):137. https:\/\/doi.org\/10.1186\/s12935-021-01824-z","journal-title":"Cancer Cell Int"},{"key":"4061_CR39","doi-asserted-by":"publisher","DOI":"10.3791\/62528","author":"S Liu","year":"2021","unstructured":"Liu S, Wang Z, Zhu R, Wang F, Cheng Y, Liu Y (2021) Three differential expression analysis methods for RNA sequencing: limma, EdgeR, DESeq2. J Vis Exp. https:\/\/doi.org\/10.3791\/62528","journal-title":"J Vis Exp"},{"key":"4061_CR40","doi-asserted-by":"publisher","first-page":"100939","DOI":"10.1016\/j.drup.2023.100939","volume":"68","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang J, Hu X, Pan Z, Xu T, Xu J, Jiang L, Huang P, Zhang Y, Ge M (2023) Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy. Drug Resist Updat 68:100939. https:\/\/doi.org\/10.1016\/j.drup.2023.100939","journal-title":"Drug Resist Updat"},{"issue":"1","key":"4061_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12920-024-01872-0","volume":"17","author":"SW Long","year":"2024","unstructured":"Long SW, Li SH, Li J, He Y, Tan B, Jing HH, Zheng W, Wu J (2024) Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology. BMC Med Genomics 17(1):99. https:\/\/doi.org\/10.1186\/s12920-024-01872-0","journal-title":"BMC Med Genomics"},{"key":"4061_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab260","journal-title":"Brief Bioinform"},{"issue":"6","key":"4061_CR43","doi-asserted-by":"publisher","first-page":"065005","DOI":"10.1088\/1478-3975\/10\/6\/065005","volume":"10","author":"CT Mierke","year":"2013","unstructured":"Mierke CT (2013) The role of focal adhesion kinase in the regulation of cellular mechanical properties. Phys Biol 10(6):065005. https:\/\/doi.org\/10.1088\/1478-3975\/10\/6\/065005","journal-title":"Phys Biol"},{"issue":"1\u20132","key":"4061_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"key":"4061_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129944","author":"E Mu\u00f1oz-S\u00e1ez","year":"2023","unstructured":"Mu\u00f1oz-S\u00e1ez E, Moracho N, Learte AIR, Collignon A, Arroyo AG, Noel A, Sounni NE, S\u00e1nchez-Camacho C (2023) Molecular Mechanisms Driven by MT4-MMP in Cancer Progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24129944","journal-title":"Int J Mol Sci"},{"key":"4061_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2019.12.015","volume":"148","author":"E Niemel\u00e4","year":"2020","unstructured":"Niemel\u00e4 E, Desai D, Niemi R, Doroszko M, \u00d6zliseli E, Kemppainen K, Rahman NA, Sahlgren C, T\u00f6rnquist K, Eriksson JE, Rosenholm JM (2020) Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer. Eur J Pharm Biopharm 148:1\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2019.12.015","journal-title":"Eur J Pharm Biopharm"},{"issue":"23","key":"4061_CR47","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1158\/0008-5472.Can-13-2994","volume":"74","author":"A Paye","year":"2014","unstructured":"Paye A, Truong A, Yip C, Cimino J, Blacher S, Munaut C, Cataldo D, Foidart JM, Maquoi E, Collignon J, Delvenne P, Jerusalem G, Noel A, Sounni NE (2014) EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP. Cancer Res 74(23):6758\u20136770. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-2994","journal-title":"Cancer Res"},{"issue":"1","key":"4061_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.31557\/apjcp.2021.22.1.131","volume":"22","author":"G Qader","year":"2021","unstructured":"Qader G, Aali M, Smail SW et al (2021) Cardiac, hepatic and renal dysfunction and IL-18 polymorphism in breast, colorectal, and prostate cancer patients. Asian Pac J Cancer Prev 22(1):131\u2013137. https:\/\/doi.org\/10.31557\/apjcp.2021.22.1.131","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"4061_CR49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaci.2020.04.044","volume":"147","author":"L Quatrini","year":"2021","unstructured":"Quatrini L, Vacca P, Tumino N, Besi F, Di Pace AL, Scordamaglia F, Martini S, Munari E, Mingari MC, Ugolini S, Moretta L (2021) Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cells. J Allergy Clin Immunol 147(1):349\u2013360. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.044","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"4061_CR50","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.biocel.2008.10.021","volume":"41","author":"G Rath","year":"2009","unstructured":"Rath G, Schneider C, Langlois B, Sartelet H, Morjani H, Btaouri HE, Dedieu S, Martiny L (2009) De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma. Int J Biochem Cell Biol 41(5):1165\u20131172. https:\/\/doi.org\/10.1016\/j.biocel.2008.10.021","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"4061_CR51","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.bbamcr.2006.08.001","volume":"1763","author":"GM Rath","year":"2006","unstructured":"Rath GM, Schneider C, Dedieu S, Rothhut B, Soula-Rothhut M, Ghoneim C, Sid B, Morjani H, El Btaouri H, Martiny L (2006) The C-terminal CD47\/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochim Biophys Acta 1763(10):1125\u20131134. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.08.001","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 24","key":"4061_CR52","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1242\/jcs.157560","volume":"127","author":"C Schoenherr","year":"2014","unstructured":"Schoenherr C, Serrels B, Proby C, Cunningham DL, Findlay JE, Baillie GS, Heath JK, Frame MC (2014) Eps8 controls Src- and FAK-dependent phenotypes in squamous carcinoma cells. J Cell Sci 127(Pt 24):5303\u20135316. https:\/\/doi.org\/10.1242\/jcs.157560","journal-title":"J Cell Sci"},{"issue":"2","key":"4061_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/iep.12268","volume":"99","author":"S \u0160elemetjev","year":"2018","unstructured":"\u0160elemetjev S, Bartolome A, I\u0161i\u0107Den\u010di\u0107 T, \u0110ori\u0107 I, Paunovi\u0107 I, Tati\u0107 S, Cveji\u0107 D (2018) Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression. Int J Exp Pathol 99(2):87\u201394. https:\/\/doi.org\/10.1111\/iep.12268","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"4061_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2015.09.001","volume":"163","author":"A Serrels","year":"2015","unstructured":"Serrels A, Lund T, Serrels B, Byron A, McPherson RC, von Kriegsheim A, G\u00f3mez-Cuadrado L, Canel M, Muir M, Ring JE, Maniati E, Sims AH, Pachter JA, Brunton VG, Gilbert N, Anderton SM, Nibbs RJ, Frame MC (2015) Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity. Cell 163(1):160\u2013173. https:\/\/doi.org\/10.1016\/j.cell.2015.09.001","journal-title":"Cell"},{"key":"4061_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan8355","author":"B Serrels","year":"2017","unstructured":"Serrels B, McGivern N, Canel M, Byron A, Johnson SC, McSorley HJ, Quinn N, Taggart D, Von Kreigsheim A, Anderton SM, Serrels A, Frame MC (2017) IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.aan8355","journal-title":"Sci Signal"},{"issue":"4","key":"4061_CR56","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","volume":"75","author":"X Song","year":"2021","unstructured":"Song X, Xu H, Wang P, Wang J, Affo S, Wang H, Xu M, Liang B, Che L, Qiu W, Schwabe RF, Chang TT, Vogl M, Pes GM, Ribback S, Evert M, Chen X, Calvisi DF (2021) Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J Hepatol 75(4):888\u2013899. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.018","journal-title":"J Hepatol"},{"issue":"4","key":"4061_CR57","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.18632\/oncotarget.14087","volume":"8","author":"K Tanabe","year":"2016","unstructured":"Tanabe K, Shinsato Y, Furukawa T, Kita Y, Hatanaka K, Minami K, Kawahara K, Yamamoto M, Baba K, Mori S, Uchikado Y, Maemura K, Tanimoto A, Natsugoe S (2016) Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma. Oncotarget 8(4):6353\u20136363. https:\/\/doi.org\/10.18632\/oncotarget.14087","journal-title":"Oncotarget"},{"issue":"4","key":"4061_CR58","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD et al (2018) The immune landscape of cancer. Immunity 48(4):812-830.e814. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023","journal-title":"Immunity"},{"issue":"3","key":"4061_CR59","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/cbm-220093","volume":"35","author":"J Tu","year":"2022","unstructured":"Tu J, Wang J, Tang B, Zhang Z, Han M, Li M, Yu J, Shen L, Zhang M, Ye J (2022) Expression and clinical significance of TYRP1, ABCB5, and MMP17 in sinonasal mucosal melanoma. Cancer Biomark 35(3):331\u2013342. https:\/\/doi.org\/10.3233\/cbm-220093","journal-title":"Cancer Biomark"},{"issue":"2","key":"4061_CR60","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3892\/ol.2014.2747","volume":"9","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yu SJ, Li YX, Luo HS (2015) Expression and clinical significance of matrix metalloproteinase-17 and -25 in gastric cancer. Oncol Lett 9(2):671\u2013676. https:\/\/doi.org\/10.3892\/ol.2014.2747","journal-title":"Oncol Lett"},{"key":"4061_CR61","doi-asserted-by":"publisher","first-page":"570604","DOI":"10.3389\/fendo.2020.570604","volume":"11","author":"Z Xie","year":"2020","unstructured":"Xie Z, Li X, He Y, Wu S, Wang S, Sun J, He Y, Lun Y, Zhang J (2020) Immune cell confrontation in the papillary thyroid carcinoma microenvironment. Front Endocrinol (Lausanne) 11:570604. https:\/\/doi.org\/10.3389\/fendo.2020.570604","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"4061_CR62","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1111\/cas.14216","volume":"110","author":"S Yang","year":"2019","unstructured":"Yang S, Liu T, Cheng Y, Bai Y, Liang G (2019) Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer. Cancer Sci 110(12):3639\u20133649. https:\/\/doi.org\/10.1111\/cas.14216","journal-title":"Cancer Sci"},{"issue":"5","key":"4061_CR63","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"issue":"5","key":"4061_CR64","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2337\/dci22-0047","volume":"46","author":"OHY Yu","year":"2023","unstructured":"Yu OHY, Suissa S (2023) Metformin and cancer: solutions to a real-world evidence failure. Diabetes Care 46(5):904\u2013912. https:\/\/doi.org\/10.2337\/dci22-0047","journal-title":"Diabetes Care"},{"issue":"8","key":"4061_CR65","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1242\/jcs.182097","volume":"129","author":"A Yurdagul Jr","year":"2016","unstructured":"Yurdagul A Jr, Sulzmaier FJ, Chen XL, Pattillo CB, Schlaepfer DD, Orr AW (2016) Oxidized LDL induces FAK-dependent RSK signaling to drive NF-\u03baB activation and VCAM-1 expression. J Cell Sci 129(8):1580\u20131591. https:\/\/doi.org\/10.1242\/jcs.182097","journal-title":"J Cell Sci"},{"issue":"2","key":"4061_CR66","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2159-8290.CD-19-0811","volume":"10","author":"H Zhang","year":"2020","unstructured":"Zhang H, Schaefer A, Wang Y, Hodge RG, Blake DR, Nathaniel Diehl J, Papageorge AG, Stachler MD, Liao J, Zhou J, Zhong W, Akarca FG, de Klerk LK, Derks S, Pierobon M, Hoadley KA, Wang TC, Church G, Wong KK, Petricoin EF, Cox AD, Lowy DR, Der CJ, Bass AJ (2020) Gain-of-function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse gastric cancer. Cancer Discov 10(2):288\u2013305. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0811","journal-title":"Cancer Discov"},{"issue":"1","key":"4061_CR67","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1186\/s12885-023-11556-0","volume":"23","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhou M, Gao X, Xie Y, Xiao J, Liu T, Zeng X (2023) Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity. BMC Cancer 23(1):1048. https:\/\/doi.org\/10.1186\/s12885-023-11556-0","journal-title":"BMC Cancer"},{"key":"4061_CR68","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3389\/fonc.2019.01314","volume":"9","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhu K, Pu H, Wang Z, Zhao H, Zhang J, Wang Y (2019) An immune-related signature predicts survival in patients with lung adenocarcinoma. Front Oncol 9:1314. https:\/\/doi.org\/10.3389\/fonc.2019.01314","journal-title":"Front Oncol"},{"issue":"3","key":"4061_CR69","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s12094-023-03284-5","volume":"26","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang J, Fan Y, Lang F, Fu F, Liu Q (2024) MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis. Clin Transl Oncol 26(3):653\u2013663. https:\/\/doi.org\/10.1007\/s12094-023-03284-5","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"4061_CR70","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17(8):807\u2013821. https:\/\/doi.org\/10.1038\/s41423-020-0488-6","journal-title":"Cell Mol Immunol"},{"key":"4061_CR71","doi-asserted-by":"publisher","first-page":"6723807","DOI":"10.1155\/2016\/6723807","volume":"2016","author":"J Zhou","year":"2016","unstructured":"Zhou J, He LL, Ding XF, Yuan QQ, Zhang JX, Liu SC, Chen G (2016) Combinatorial antitumor effect of rapamycin and \u03b2-elemene in follicular thyroid cancer cells. Biomed Res Int 2016:6723807. https:\/\/doi.org\/10.1155\/2016\/6723807","journal-title":"Biomed Res Int"},{"issue":"3","key":"4061_CR72","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00262-018-2289-7","volume":"68","author":"R Zhou","year":"2019","unstructured":"Zhou R, Zhang J, Zeng D, Sun H, Rong X, Shi M, Bin J, Liao Y, Liao W (2019) Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer. Cancer Immunol Immunother 68(3):433\u2013442. https:\/\/doi.org\/10.1007\/s00262-018-2289-7","journal-title":"Cancer Immunol Immunother"},{"issue":"7817","key":"4061_CR73","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41586-020-2422-6","volume":"583","author":"T Zhou","year":"2020","unstructured":"Zhou T, Damsky W, Weizman OE, McGeary MK, Hartmann KP, Rosen CE, Fischer S, Jackson R, Flavell RA, Wang J, Sanmamed MF, Bosenberg MW, Ring AM (2020) IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature 583(7817):609\u2013614. https:\/\/doi.org\/10.1038\/s41586-020-2422-6","journal-title":"Nature"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04061-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T06:15:43Z","timestamp":1749881743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04061-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":73,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04061-9","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval of the research protocol by an institutional review board: This study adhered to the Declaration of Helsinki and was approved by the Institutional Review Board at The First Hospital of Changsha. Informed consent: Written informed consent was obtained from all patients who provided samples.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"221"}}